CHAPEL HILL, N.C., Aug. 15 /PRNewswire/ -- The U.S. hospital marketplace is multifaceted and can be divided into multiple market segments. In this challenging marketplace, pharmaceutical and biotechnology sales people must negotiate increasingly complex organizational and decision-making structures to effectively represent their brands. Hospital formulary decisions are not only being influenced by medical professionals focused on efficacy and safety but also by administrative personnel focused on operational efficiency and cost. Impactful benchmark research originally conducted by Best Practices, LLC in 2006 focused on understanding the variables in developing an effective sales force to service the hospital marketplace has been updated and published with comparisons drawn between current and historical data as appropriate.
In a benchmarking study that included such influential companies as Abbott, Astra Zeneca, Bayer, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, Procter & Gamble, Sanofi-Aventis, Schering-Plough, and Wyeth, key benchmark metrics and executive insights provide a basis for informing decision-making around critical structure, resource and process planning and execution.
For a complimentary summary of the full report "Sales Force
Effectiveness: Benchmarking the Resources and Structure Required to Service
the U.S. Hospital Marketplace," click on the following link
Key topic areas in the research include:
-- Targeting Key Decision Makers and Influencers
-- Hospital Sales Force Alignment, Structure and Support
-- Hospital Sales Force Training
-- GPO Focus
-- Lessons Learned
For more information on this report, contact Robert Naylor at
firstname.lastname@example.org or (919) 767-9244. To access the full report or
download a complimentary copy of the report summary
|SOURCE Best Practices, LLC|
Copyright©2008 PR Newswire.
All rights reserved